revolutionizing Primary Care: AI Eye Scans for early Heart Disease Detection

A recent study highlights the potential of AI-driven retinal scans as a powerful tool for identifying cardiovascular disease (CVD) risk factors, particularly within primary care settings. This non-invasive, rapid screening method could be seamlessly integrated into routine general practice, enabling early detection of individuals at risk of heart attacks and strokes.This proactive approach could significantly improve patient outcomes and reduce the burden of CVD, which remains a leading cause of death globally. According to the World health Association (WHO), an estimated 17.9 million people died from CVDs in 2019, representing 32% of all global deaths.

Expert Insights on Implementation and Accuracy

Wenyi Hu, the lead author of the study, emphasizes the ease of use and high acceptance rates among both physicians and patients as key advantages of this technology.The simplicity of the retina camera and the high acceptance by both doctors and patients prove that this technology can be included in the daily practice of general practitioners, which makes screening possible prior to a general practitioner, Hu stated. However, Hu also acknowledges the need for further research, particularly to refine the technology’s accuracy across diverse patient demographics, such as older men. The findings were recently published in NPJ Digital Medicine.

Study Design and Methodology: A Closer look

The research, conducted as part of Hu’s doctoral work at the University of Melbourne in collaboration with cera’s Ophthalmic Epidemiology team, involved 361 participants aged 45 to 70. All participants were patients at two general practices and had recently undergone standard cardiovascular risk assessments, including blood pressure and cholesterol tests.

Each participant underwent a retinal scan using a specialized camera that mapped the blood vessels at the back of the eye. The AI technology then generated a real-time report outlining the patient’s cardiovascular risk profile.This was compared to assessments based on the WHO’s CVD risk prediction charts, which consider factors like age, gender, smoking habits, blood pressure, and cholesterol levels.

Key Findings: Accuracy and Patient Satisfaction

The study yielded several significant findings:

• A moderate correlation was observed between the retinal scan results and the WHO risk scores, with 67.4% of results aligning. The scan overestimated risk in 17.1% of cases and underestimated it in 19.5%.
• The retinal scan’s predictive accuracy for estimating the 10-year risk of coronary heart disease or stroke was comparable to the WHO method, as validated against data from the UK Biobank.
• The technology demonstrated high reliability in clinical practice, with a 93.9% success rate in obtaining usable images.
• High levels of satisfaction were reported by both patients (92.5%) and general practitioners (87.5%) regarding the technology.

Integrating Retinal Scans into Routine Healthcare

Dr. Malcolm clark, a general practitioner and co-author of the study, emphasizes the potential of retinal scans to enhance cardiovascular risk assessment in general practice.He envisions the technology as a valuable tool for early identification of patients who may require further investigation.

In the future,I imagine that patients automatically receive a reminder via SMS to have an eye scan made,which then sends a risk report to their doctor. This could be included in regular health checks, such as cervical cancer or colon cancer screening,

Dr. Malcolm Clark, General Practitioner and Co-author of the study

The Broader Impact: AI’s Role in Preventive Healthcare

Association teacher Lisa Zhuoting Zhu, who supervised the research, views the integration of AI-driven eye scans as a crucial step towards improving public health. We are working on a future in which cheaper, scalable and accessible cardiovascular screening is possible for everyone, including people in remote or vulnerable communities, Zhu stated.

Zhu further suggests that AI-powered eye scans could provide valuable insights into the health of not only the heart and blood vessels but also the brain and kidneys, positioning the technology as a cornerstone of routine preventive healthcare that extends beyond traditional screening methods.

Beyond Cardiovascular Disease: AI and Eye Imaging in Diagnostics

The application of AI to analyze eye images extends beyond cardiovascular risk assessment.For example, the PupilSense app, developed last year, uses smartphone camera images of the eyes to detect depression by analyzing pupil reflexes. A trial involving 25 volunteers showed a 76% correlation between the AI tool’s assessment and self-reported mood fluctuations.

Furthermore, in 2023, researchers developed an AI algorithm capable of diagnosing autism spectrum disorder (ASD) in children using eye photos. In a study of 958 children, half of whom had already been diagnosed with ASD, the AI tool achieved 100% accuracy in identifying the condition. The algorithm analyzed retinal images, which can provide valuable facts about the nervous system, to differentiate between ASD and typical growth.